Page last updated: 2024-10-29

indapamide and Acute Myelogenous Leukemia

indapamide has been researched along with Acute Myelogenous Leukemia in 2 studies

Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Borghi, C2
Jayagopal, PB2
Konradi, A1
Bortolotto, LA2
Degli Esposti, L2
Perrone, V2
Snyman, JR2
Konradi, AO1

Other Studies

2 other studies available for indapamide and Acute Myelogenous Leukemia

ArticleYear
Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
    Advances in therapy, 2023, Volume: 40, Issue:4

    Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension;

2023
A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    Journal of hypertension, 2024, Jan-01, Volume: 42, Issue:1

    Topics: Adult; Amlodipine; Antihypertensive Agents; Drug Combinations; Health Care Costs; Humans; Hypertensi

2024